[1] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020,396(10258):1204-1222. DOI: 10.1016/S0140-6736(20)30925-9.
[2] GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020,396(10258):1223-1249. DOI: 10.1016/S0140-6736(20)30752-2.
[3] GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020,396(10258):1160-1203. DOI: 10.1016/S0140-6736(20)30977-6.
[4] GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet Neurol, 2017,16(11):877-897. DOI: 10.1016/S1474-4422(17)30299-5.
[5] 高一鹭,王文志. 中国脑卒中疾病负担研究[C]//2015第十五次中国脑血管病大会论文集.南京,2015:348.
[6] 郭洪菊,李玥伶,王娟. 阿尔茨海默病与帕金森病疾病负担研究分析[J]. 慢性病学杂志,2018,19(11). DOI:10.16440/j.cnki.1674-8166.2018.11.015.
[7] GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018 392(10159):1789-1858. DOI: 10.1016/S0140-6736(18)32279-7.
[8] GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018,392(10159):1859-1922. DOI: 10.1016/S0140-6736(18)32335-3.
[9] Innes K, Hooper J, Bramley M, et al. Creation of a clinical classification. International statistical classification of diseases and related health problems--10th revision, Australian modification (ICD-10-AM)[J]. Health Inf Manag, 1997,27(1):31-38.
[10] Deng Y, Yang D, Yu JM, et al. The association of socioeconomic status with the burden of cataract-related blindness and the effect of ultraviolet radiation exposure: an ecological study[J]. Biomed Environ Sci, 2021,34(2):101-109. DOI: 10.3967/bes2021.015.
[11] Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med, 2000,19(3):335-351. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z.
[12] Ilic M, Ilic I. Worldwide suicide mortality trends (2000-2019): a joinpoint regression analysis[J]. World J Psychiatry, 2022,12(8):1044-1060. DOI: 10.5498/wjp.v12.i8.1044.
[13] Clegg LX, Hankey BF, Tiwari R, et al. Estimating average annual per cent change in trend analysis[J]. Stat Med, 2009,28(29):3670-3682. DOI: 10.1002/sim.3733.
[14] 段朝晖,张敏,徐杰茹,等. 2000—2019年中国脑瘤死亡趋势分析及预测研究[J]. 中国全科医学,2023,26(6):734-741. DOI:10.12114/j.issn.1007-9572.2022.0630..
[15] Dong Z, Wang QQ, Yu SC, et al. Age-period-cohort analysis of pulmonary tuberculosis reported incidence, China, 2006-2020[J]. Infect Dis Poverty, 2022,11(1):85. DOI: 10.1186/s40249-022-01009-4.
[16] 袁空军,杨媛,赵创艺,等. 1990-2019年中国高血清低密度脂蛋白胆固醇疾病负担趋势分析与预测[J]. 现代预防医学,2022,49(14):2502-2509. DOI:10.20043/j.cnki.MPM. 202112618.
[17] 赵创艺,袁空军,杨媛,等. 基于ARIMA与NNAR模型的中国慢性阻塞性肺疾病疾病负担预测研究[J]. 中国全科医学,2022,25(16):1942-1949. DOI:10.12114/j.issn.1007- 9572. 2022.0045.
[18] 文小焱,潘惊萍,段占祺,等. 2015-2017年四川省心脑血管疾病负担研究[J]. 中国慢性病预防与控制,2021,29(1):14-17. DOI:10.16386/j.cjpccd.issn.1004-6194. 2021.01.003.
[19] Feigin VL, Vos T. Global burden of neurological disorders: from Global Burden of Disease estimates to actions[J]. Neuroepidemiology, 2019,52(1-2):1-2. DOI: 10.1159/000495197.
[20] 买力曼·巴哈尼,萨拉瓦提·哈日特别克,聂艳武,等. 基于年龄-时期-队列模型分析2006-2020年中国冠心病死亡趋势[J]. 现代预防医学,2023,50(2):193-198. DOI:10.20043/j.cnki.MPM.202207042.
[21] 陈心广,王培刚. 中国社会变迁与国民健康动态变化[J]. 中国人口科学,2014,28(2):63-73.
[22] 高艳多,吴凯,朱慈华,等.武汉市江岸区2000-2014年脑血管疾病死亡趋势的年龄-时期-队列模型分析[J].中华疾病控制杂志,2017,21(02):118-122.DOI:10.16462/j.cnki.zhjbkz.2017.02.004.
[23] Sørensen HT. Global burden of neurological disorders: challenges and opportunities with the available data[J]. Lancet Neurol, 2019,18(5):420-421. DOI: 10.1016/S1474-4422(19)30027-4.
[24] 国务院办公厅关于印发中国防治慢性病中长期规划(2017-2025年)的通知[J].中华人民共和国国务院公报,2017(7):17-24.
[25] 中共中央国务院印发«"健康中国2030"规划纲要»[J].中华人民共和国国务院公报,2016(32):5-20.
[26] India State-Level Disease Burden Initiative Neurological Disorders Collaborators. The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990-2019[J]. Lancet Glob Health, 2021,9(8):e1129-e1144. DOI: 10.1016/S2214-109X(21)00164-9.
[27] Stovner LJ, Hoff JM, Svalheim S, et al. Neurological disorders in the Global Burden of Disease 2010 study[J]. Acta Neurol Scand Suppl, 2014 (198):1-6. DOI: 10.1111/ane.12229.
[28] Sejvar JJ. Global burden of neurological disease: what's in a name?[J]. Lancet Neurol, 2017,16(11):858-859. DOI: 10.1016/S1474-4422(17)30333-2.
|